Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001005286-25-000069
Filing Date
2025-04-16
Accepted
2025-04-16 16:37:56
Documents
3
Period of Report
2025-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1744835868.html 3  
1 FORM 3 wk-form3_1744835868.xml 3 2278
2 EX-24 lifecoresection16powerof.htm EX-24 3681
3 lifecoresection16powerof001.jpg GRAPHIC 249525
  Complete submission text file 0001005286-25-000069.txt   351211
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3515 LYMAN BLVD CHASKA MN 55318
Business Address
Salus Thomas D. (Reporting) CIK: 0002062209 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27446 | Film No.: 25843252